Pharmaceutical market now ‘risky’

Geographical indicators to be developed for kava

A leading kava scientist in the Pacific has labelled as "risky" any kava comeback in the pharmaceutical market, stressing that success of the crop as an export commodity will be in the "food" market.

In an interview with Islands Business, Dr Vincent Lebot said kava is now considered a "food" product internationally in the WHO/FAO Codex Alimentarius and efforts should be put into developing "Geographical Indicators" or GIs to help further its potentials in the export markets.

"GIs are used to designate a product . . .

Please Subscribe to view full content...

Register New Account

Choose your membership level

Choose Your Payment Method

Share article:

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print